Code: Q5107

Description:
Description: Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
HCPCS Category: Temporary codes (limited use and guidelines specific)
Other Descriptions:
MVASI BS 400 MG INJ
BEVACIZUMAB-AWWB 25 MG/ML INTRAVENOUS SOLUTION
BEVACIZUMAB-AWWB (MVASI) 400MG/16ML JW
BEVACIZUMAB-AWWB (MVASI) 100 MG/4ML JW
BEVACIZUMAB-AWWB (MVASI) 100 MG/4ML VIAL
BEVACIZUMAB-AWWB (MVASI)400MG/16 ML VIAL
ONCO MVASI 400MG/16ML VIAL
BEVACIZUMAB+AC0-AWWB 10 MG(400 MG)
Inj mvasi 10 mg
Related codes:
Code: Q5101
ZARXIO BS 480 MCG INJ
Code: Q5102
Description: Injection, infliximab, biosimilar, 10 mg
HCPCS Category: Temporary codes (limited use and guidelines specific)
Code: Q5103
INFLECTRA BS 10 MG INJ
Code: Q5104
RENFLEXIS BS 100 MG INJ
Code: Q5105
RETACRIT BS 100U ESRD
Code: Q5106
RETACRIT BS 3000U NESRD
Code: Q5108
FULPHILA BS 6 MG INJ
Code: Q5109
Description: Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg
HCPCS Category: Temporary codes (limited use and guidelines specific)
State Average # Hospitals In Database
New York (NY) $61 1
New Jersey (NJ) $64 1
Washington (WA) $65 2
Oklahoma (OK) $89 3
Massachusetts (MA) $94 8
South Dakota (SD) $99 1
Minnesota (MN) $136 1
Vermont (VT) $139 1
Alaska (AK) $190 2
California (CA) $201 23
Delaware (DE) $203 1
North Dakota (ND) $374 2
Hawaii (HI) $416 6
Nebraska (NE) $432 11
Iowa (IA) $432 3
Wisconsin (WI) $551 19
Tennessee (TN) $740 7
Indiana (IN) $854 13
Illinois (IL) $864 1
Maryland (MD) $870 8
Connecticut (CT) $988 5
Nevada (NV) $1,081 3
West Virginia (WV) $1,269 3
Alabama (AL) $1,401 3
New Mexico (NM) $4,034 2
Michigan (MI) $4,572 26
Texas (TX) $5,726 8
North Carolina (NC) $5,828 25
Georgia (GA) $6,273 12
Kansas (KS) $6,405 6
Kentucky (KY) $7,109 4
Missouri (MO) $8,028 8
Idaho (ID) $8,125 4
Virginia (VA) $8,411 4
Florida (FL) $8,603 50
Louisiana (LA) $11,576 2
New Hampshire (NH) $12,117 7
Ohio (OH) $12,158 11
South Carolina (SC) $12,450 1
Utah (UT) $17,492 1

ChargemasterDB by Joseph Paul Cohen
A database of US hospital prices based on data made available by the Centers for Medicare & Medicaid Services (CMS), HHS price transparancy rule 45 CFR ยง180.